Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K.

British Journal of Dermatology

Volumn 163, Issue 3, 2010, Pages 586-592

  Abuabara, K ^a   Azfar, R S ^a   Shin, D B ^a   Neimann, A L ^b   Troxel, A B ^a   Gelfand, J M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cancer; cardiovascular epidemiology; infection; mortality; psoriasis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ETRETIN; ETRETINATE; HYDROXYUREA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSORALEN;

ACCIDENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENERAL PRACTICE; HUMAN; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RESPIRATORY TRACT DISEASE; SUICIDE; SYSTEMIC THERAPY;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RISK FACTORS;

EID: 77955898585     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09941.x     Document Type: Article

References (61)

1. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Database. In:Pharmacoepidemiology (Strom BL, ed. 4th edn. Philadelphia:John Wiley & Sons, Ltd, 2005 337 346.
2. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009 60:218 224.
3. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med 2009 122:1150.
4. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010 29:10 15.
5. Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008 58:1031 1042.
6. Naldi L, Mercuri SR. Epidemiology of comorbidities in psoriasis. Dermatol Ther 2010 23:114 118.
7. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004 9:140 147.
8. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001 137:280 284.
9. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005 64 (Suppl. 2 ii18 23.
10. van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009 121:154 161.
11. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010 in press).
12. Fortes C, Mastroeni S, Leffondre K et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005 141:1580 1584.
13. Higgins E. Alcohol, smoking and psoriasis. Clin Exp Dermatol 2000 25:107 110.
14. Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther 2010 23:174 180.
15. Gelfand JM, Dommasch ED, Shin DB et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009 129:2411 2418.
16. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296:1735 1741.
17. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 156:271 276.
18. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55:829 835.
19. Gelfand JM, Troxel AB, Lewis JD et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007 143:1493 1499.
20. Mehta NN, Azfar RS, Shin DB et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010 31:902 904.
21. Lindegard B. Mortality and causes of death among psoriatics. Dermatologica 1989 179:91 2.
22. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004 19:225 230.
23. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988 91:197 201.
24. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999 135:1490 1493.
25. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008 26 (Suppl. 51 S62 5.
26. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007 143:1559 1565.
27. Herrett E, Thomas SL, Schoonen WM et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010 69:4 14.
28. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010 60:e128 36.
29. Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 2008 159:1331 1337.
30. Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009 160:1048 1056.
31. Margolis D, Bilker W, Hennessy S et al. The risk of malignancy associated with psoriasis. Arch Dermatol 2001 137:778 783.
32. Minino AM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004. Natl Vital Stat Rep 2007 55:1 119.
33. Singh NP, Prakash A, Kubba S et al. Psoriatic nephropathy - does an entity exist? Ren Fail 2005 27:123 127.
34. Szepietowski JC, Szepietowski T. Is renal function altered in patients with psoriasis vulgaris? A short review. J Dermatol 2000 27:569 572.
35. Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc 2009 108:754 764.
36. Dickstein DL, Walsh J, Brautigam H et al. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 2010 77:82 102.
37. McNaull BB, Todd S, McGuinness B, Passmore AP. Inflammation and anti-inflammatory strategies for Alzheimer's disease - a mini-review. Gerontology 2010 56:3 14.
38. Nagai M, Hoshide S, Kario K. Hypertension and dementia. Am J Hypertens 2010 23:116 124.
39. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009 8:1006 1018.
40. Prey S, Paul C, Bronsard V et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010 24 (Suppl. 2 23 30.
41. Dommasch E, Gelfand JM. Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther 2009 22:418 430.
42. Gelfand JM, Berlin J, van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003 139:1425 1429.
43. Gelfand JM, Shin DB, Neimann AL et al. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006 126:2194 2201.
44. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 1997 336:1041 1045.
45. Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 2009 27:1017 1025.
46. Gisondi P, Del Giglio M, Cozzi A, Girolomoni G. Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther 2010 23:155 159.
47. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008 20:416 422.
48. Cohen AD, Dreiher J, Shapiro Y et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 2008 22:585 589.
49. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 298:321 328.
50. Gupta MA, Schork NJ, Gupta AK et al. Suicidal ideation in psoriasis. Int J Dermatol 1993 32:188 190.
51. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004 45:155 159.
52. Dreiher J, Weitzman D, Shapiro J et al. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol 2008 159:956 960.
53. Grossman RM, Chevret S, Abi-Rached J et al. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol 1996 132:623 629.
54. Kimball AB, Jacobson C, Weiss S et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005 6:383 392.
55. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996 313:919 921.
56. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008 21:54 9.
57. Hoare J. Comparison of area-based inequality measures and disease morbidity in England, 1994-1998. Health Stat Q 2003 18:18 24.
58. Hulley SB, Cummings SR, Browner WS et al. Designing Clinical Research: an Epidemiologic Approach, 3rd edn. Philadelphia:Lippincott Williams & Wilkins, 2006.
59. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010 130:962 967.
60. Ministry of Justice. Statistics on Deaths Reported to Coroners: England and Wales, 2009. Ministry of Justice Statistics Bulletin, 2010. Available at: http://www.justice.gov.uk/publications/coronersannual.htm (last accessed 3 July 2010).
61. Burton JL, Underwood J. Clinical, educational, and epidemiological value of autopsy. Lancet 2007 369:1471 1480.